Identità

Resmetirom Impurity 47

Non indicato · C20H17Cl2N3O3

01Identità

Lazychem IDLC-36902
CAS RNNon indicato
PubChem CID90077923
Molecular formulaC20H17Cl2N3O3
Molecular weight418.3 g/mol
IUPAC nameN-[3,5-dichloro-4-[(6-oxo-5-prop-1-en-2-yl-4,5-dihydro-1H-pyridazin-3-yl)oxy]phenyl]benzamide
InChIKeyOFOYVCUGSNKIHP-UHFFFAOYSA-N

02Struttura e stereochimica

Two-dimensional chemical structure of Resmetirom Impurity 47
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count3
Secondary amines0
Tertiary amines0
SMILESCC(=C)C1CC(=NNC1=O)OC2=C(C=C(C=C2Cl)NC(=O)C3=CC=CC=C3)Cl
InChINon indicato

03Stereochemistry

The published structure contains 0 defined and 1 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres1Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Stato in India

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nomi e relazioni

API e farmaco progenitore

Non indicato

Nomi e relazioni

    06Fonti